Critical Reviews in Oncology / Hematology
Volume 74, Supplement 1 , Pages S11-S15, April 2010

Routine adjuvant use of bisphosphonates in breast cancer Arguments in favour and against

  • Ingo Diel

      Affiliations

    • Center for Gynecological Oncology, Mannheim, Germany
    • Corresponding Author InformationCorresponding authors. Ingo Diel, MD. Professor of Gynecology and Obstetrics, Center for Gynecological Oncology, Quadrat P 7, 16–18, 68161 Mannheim, Germany
    • ,
  • Stefan Aebi

      Affiliations

    • Breast and Gynecologic Cancer Center, Departments of Gynecology and Medical Oncology, University Hospital, Berne, Switzerland
    • Corresponding Author InformationStefan Aebi, MD. Associate Professor of Medical Oncology, University of Berne, Switzerland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(10)70005-6

doi:10.1016/S1040-8428(10)70005-6

Critical Reviews in Oncology / Hematology
Volume 74, Supplement 1 , Pages S11-S15, April 2010

Article Tools